180
Clin. Cardiol. Vol. 25, April 2002
References
12. Hollister AS, Rodeheffer RJ, White FJ, Potts JR, Imada T, Inagami
T: Clearance of atrial natriuretic factor by lung, liver, and kidney in
human subjects and the dog. J Clin Invest 1989;83:623–628
1
.
Raine AE, Erne P, Burgisser E, Muller FB, Bolli P, Burkart F,
Buhler FR: Atrial natriuretic peptide and atrial pressure in patients
with congestive heart failure. N Engl J Med 1986;315:533–537
Tamamori M, Ito H, Hiroe M, Marumo F, Hata RI: Stimulation of
collagen synthesis in rat cardiac fibroblasts by exposure to hypoxic
culture conditions and suppression of the effect by natriuretic pep-
tides. Cell Biol Int 1997;21:175–180
Kohno M, Horio T, Yokokawa K, Yasunari K, Ikeda M, Minami M,
Kurihara N, Takeda T: Brain natriuretic peptide as a marker for hy-
pertensive left ventricular hypertrophy: Changes during 1-year an-
tihypertensive therapy with angiotensin-converting enzyme in-
hibitor. Am J Med 1995;98:257–265
Thibault G, Murthy KK, Gutkowska J, Seidah NG, Lazure C,
Chretien M, Cantin M: NH2-terminal fragment of rat pro-atrial na-
triuretic factor in the circulation: Identification, radioimmunoassay
and half-life. Peptides 1988;9:47–53
Hall C, Aaberge L, Stokke O: In vitro stability of N-terminal proa-
trial natriuretic factor in unfrozen samples: An important prerequi-
site for its use as a biochemical parameter of atrial pressure in clini-
cal routine (letter). Circulation 1995;91:911
Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA,
Turner JG, Buttimore RC, Lainchbury JG, Elliott JM, Ikram H,
Crozier IG, Smyth DW: Plasma N-terminal pro-brain natriuretic
peptide and adrenomedullin: New neurohormonal predictors of left
ventricular function and prognosis after myocardial infarction.
Circulation 1998;97:1921–1929
Braunwald E: Aortic stenosis. In Heart Disease: A Textbook of
Cardiovascular Medicine. 5th Ed., p. 1035–1045. Philadelphia:
W.B. Saunders, 1997
Qi W, Mathisen P, Simonsen S, Bjørnerheim R, Endresen K,
Kjekshus J, Hall C: Brain natriuretic peptide in patients with aortic
stenosis: Comparison with N-terminal proatrial natriuretic peptide
and atrial natriuretic peptide. Eur Heart J 1998;19(suppl):409
Ihlen H, Molstad P: Cardiac output measured by Doppler echocar-
diography in patients with aortic prosthetic valves. Eur Heart J
13. Marumo F, Matsubara O, Masaki Y, Togashi K, Ando K, Hasegawa
N: Degradation and distribution of brain natriuretic peptide in
porcine tissues. J Endocrinol 1992;132:101–106
2.
14. Rademaker MT, Charles CJ, Kosoglou T, Protter AA, Espiner EA,
Nicholls MG, Richards AM: Clearance receptors and endopepti-
dase: Equal role in natriuretic peptide metabolism in heart failure.
Am J Physiol 1997;273:2372–2379
3.
1
5. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN,
Espiner EA: Immunoreactive amino-terminal pro-brain natriuretic
peptide (NT- PROBNP): A new marker of cardiac impairment.
Clin Endocrinol 1997;47:287–296
4.
1
6. Obata K, Yasue H, Okumura K, Matsuyama K, Ogawa H, Kurose
M, Saito Y, Nakao K, Imura H, Nobuyoshi M: Atrial natriuretic
polypeptide is removed by the lungs and released into the left atri-
um as well as the right atrium in humans. J Am Coll Cardiol 1990;
5.
15:1537–1543
1
7. Northridge DB, Jamieson MP, Jardine AG, MacArthur KJ,
MacFarlane N, Dargie HJ: Pulmonary extraction and left atrial se-
cretion of atrial natriuretic factor during cardiopulmonary bypass
surgery. Am Heart J 1992;123:698–703
6.
18. Sutton M, Plappert T, Spiegel A, Raichlen J, Douglas P, Reichek N,
Edmunds L: Early postoperative changes in left ventricular chamber
size, architecture, and function in aortic stenosis and aortic regurgi-
tation and their relation to intraoperative changes in afterload: A
prospective two-dimensional echocardiographic study. Circulation
1987; 76:77–89
7.
1
9. Monrad ES, Hess OM, Murakami T, Nonogi H, Corin WJ, Krayen-
buehl HP: Time course of regression of left ventricular hypertrophy
after aortic valve replacement. Circulation 1988;77:1345–1355
8.
2
0. Jin XY, Zhang ZM, Gibson DG, Yacoub MH, Pepper JR: Effects of
valve substitute on changes in left ventricular function and hyper-
trophy after aortic valve replacement. Ann Thorac Surg 1996;62:
9.
683–690
1990;11:399–402
2
1. Kuhl H, Puschmann D, Hoffmann R, Schondube F, Franke A,
Hanrath P: Regression of left ventricular mass one year after valve
replacement for severe aortic stenosis is dependent on prosthetic
valve size: A three-dimensional echocardiographic study. J Am
Coll Cardiol 2000;35(suppl A):442A
1
0. Devereux RB, Reichek N: Echocardiographic determination of left
ventricular mass in man. Anatomic validation of the method.
Circulation 1977;55:613–618
1
1. Sundsfjord JA, Thibault G, Larochelle P, Cantin M: Identification
and plasma concentrations of the N-terminal fragment of proatrial
natriuretic factor in man. J Clin Endocrinol Metab 1988;66:
22. Rahimtoola, SH: The problem of valve prosthesis-patient mis-
605–610
match. Circulation 1978;58:20–24